Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Evaluation of Adverse Drug Reactions and their Management in Psychiatric in-Patients


Affiliations
1 Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, Karnataka- 575018, India
2 Department of Psychiatry, Justice K.S. Hegde Charitable Hospital, Mangalore, Karnataka- 575018, India
     

   Subscribe/Renew Journal


Objective: To identify the adverse drug reactions caused by psychotropic drugs and to evaluate the causality, severity, preventability and management of those Adverse Drug Reactions (ADRs). Methods: A prospective observational study was carried out in hospitalised patients with psychiatric disorders. All the in-patients prescribed with psychotropic drugs were enrolled in the study and followed regularly for the identification of ADRs. Identified ADRs were assessed for causality, severity and preventability using various scales. Approaches towards the management of the ADRs and the patient outcomes were analysed. Results: A total of 200 patients were monitored, of which 79 ADRs were identified from 56 patients. The most commonly reported ADRs were tremor (18.98%) followed by drowsiness (17.72%). Olanzapine was found to be associated with more number of ADRs (29.11%) followed by Clozapine (12.65%). Causality assessment using World Health Organisation- Uppsala Monitoring Centre (WHO-UMC) scale showed that most of the ADRs were probable (62.02%) and possible (37.97%). Severity assessment revealed that 54.42% of ADRs were found to be moderately severe. 48.10% of ADRs were definitely preventable and 44.30% were probably preventable. Assessment on the management of ADRs says that most of them were resolved by specific treatment approach to the reaction. Conclusion: The end results of the study created the evidence on the incidence of ADRs in patients prescribed with psychotropic drugs. The study emphasises on monitoring of those drugs that are considered to have high risk in developing ADRs. Thus, it can influence to a chance of preventing or reducing an unwanted reaction.

Keywords

Adverse Drug Reaction, Psychiatry, Psychotropic Drugs.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Sadock BJ, Sadock VA, Ruiz P. Synopsis of Psychiatry. 11th edition. Philadelphia: Wolters Kluwer; 2015:910-1

  • Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy a pathophysiologic approach. 9th edition. New York: Mc GrawHills Education; 2014:799

  • Gummadi T, Harave VS, Aiyar LN, Rajalekshmi SG, Kunnavil R. Adverse drug reaction monitoring in a tertiary care psychiatry setting: a comparative study between inpatients and outpatients. Indian J Psychol Med 2017; 39:306-9

  • Antai-Otong D. Adverse drug reactions associated with antipsychotics, antidepressants and mood stabilizers. Nurs Clin N Am 2003; 38:161-76

  • Lucca JM, Madhan R, Parthasarathi G, Ram D. Identification and management of adverse effects of antipychotics in tertiary care teaching hospital. J Res Pharm Pract 2014; 3:46-50

  • Singh H, Yacob M, Sabu L, Mamatha k. Adverse drug reactions monitoring of psychotropic drugs: a tertiary care centre study. Open J Psychiatry Allied Sci 2017;8:134-8

  • Rohilla A, Yadav S. Adverse drug reactions: An overview. IJPR 2013;3:53-56

  • Parthasarathy G, Nyfort K, Hansen, Nahata MC. A textbook of Clinical Pharmacy Practice. 2nd edition. Hyderabad: Universities Press (India) private limited; 2012. Pg. no:105-18

  • Sridhar SB, Thamer SSF, Jabbar R. Monitoring of adverse drug reactions in psychiatry outpatient department of the secondary care hospital of Ras Al Khaimah, UAE. J basic Clin Pharma 2016; 7:80-6

  • Naranjo CA, Busto U, sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:243-7

  • The use of the WHO-UMC system for standardized case causality assessment. Available from: http://www.who.int/medicines/areas/qualitysafety/safetyefficacy/WHOcausalityassessment.pdf. [Last accessed on 2018 April 10].

  • Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse reactions. Am J Hosp Pharm 1992;49: 2229-39

  • Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27:538

  • Sengupta G, Bhowmick S, Hazra A, Dutta A, Rahman M. Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital. Indian J Pharmacol 2011; 43:36-9

  • Murthy MK, Singh H, Thakur SR. A study of adverse drug reactions associated with antidepressant drugs among female patients attending the department of psychiatry. Minerva Med 2017; 58:90-6

  • Nalini R. Pharmacovigilance study in psychiatry out-patient department of a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2017;6: 2375-9

  • Hotha PP, Jadav SP, Trivedi HR. Adverse drug reactions: a retrospective review of hospitalized psychiatric patients at tertiary care hospital. Int J Basic Clin Pharmacol 2016;5: 2051-60

  • Laxmi P, Venkatesh K, Divya G, Prasad T SD, Kishore SRV, Ranganayakulu D. A study on adverse reactions of antipsychotic in psychiatric patients of south India hospital. J Pharm Res 2014;3: 153-5

  • Harichandran DT, Viswanathan MT, Gangadhar R. Adverse drug reactions among hospitalized patients in psychiatry department in a tertiary care hospital. J Health Res Rev 2016; 3:77-80

  • Gawali UP, Kesari HV, Gawand KS. Adverse drug reaction profile at psychiatry out-patient department of tertiary care hospital. Int J Basic Clin Pharmacol 2017:6:2428-33

  • Chakravarty P, Neog P, Dewan B. Study of adverse drug reactions of typical antipsychotic drugs in the department of psychiatry in a tertiary care hospital of Assam. Open J Psychiatry Allied Sci 2017; 8:24-8

  • Munoli S, Patil SB. Adverse drug reaction monitoring of antipsychotic drugs and mood stabilizers in a teaching hospital. Int J Pharmacol. Clin Sci. 2016; 5:118-21

  • Shah A, Preeti P, Chaudrari M, Vataliya A. A prospective study of adverse drug reactions in patients with bipolar disorder in psychiatry outpatient department of a tertiary care hospital. J Clin Diagn Res 2017; 11:24-8


Abstract Views: 367

PDF Views: 0




  • Evaluation of Adverse Drug Reactions and their Management in Psychiatric in-Patients

Abstract Views: 367  |  PDF Views: 0

Authors

Chinnu Scaria
Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, Karnataka- 575018, India
Ananthu Satheesh
Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, Karnataka- 575018, India
Pooja Prabhakar
Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, Karnataka- 575018, India
Juno J. Joel
Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, Karnataka- 575018, India
Shishir Kumar
Department of Psychiatry, Justice K.S. Hegde Charitable Hospital, Mangalore, Karnataka- 575018, India

Abstract


Objective: To identify the adverse drug reactions caused by psychotropic drugs and to evaluate the causality, severity, preventability and management of those Adverse Drug Reactions (ADRs). Methods: A prospective observational study was carried out in hospitalised patients with psychiatric disorders. All the in-patients prescribed with psychotropic drugs were enrolled in the study and followed regularly for the identification of ADRs. Identified ADRs were assessed for causality, severity and preventability using various scales. Approaches towards the management of the ADRs and the patient outcomes were analysed. Results: A total of 200 patients were monitored, of which 79 ADRs were identified from 56 patients. The most commonly reported ADRs were tremor (18.98%) followed by drowsiness (17.72%). Olanzapine was found to be associated with more number of ADRs (29.11%) followed by Clozapine (12.65%). Causality assessment using World Health Organisation- Uppsala Monitoring Centre (WHO-UMC) scale showed that most of the ADRs were probable (62.02%) and possible (37.97%). Severity assessment revealed that 54.42% of ADRs were found to be moderately severe. 48.10% of ADRs were definitely preventable and 44.30% were probably preventable. Assessment on the management of ADRs says that most of them were resolved by specific treatment approach to the reaction. Conclusion: The end results of the study created the evidence on the incidence of ADRs in patients prescribed with psychotropic drugs. The study emphasises on monitoring of those drugs that are considered to have high risk in developing ADRs. Thus, it can influence to a chance of preventing or reducing an unwanted reaction.

Keywords


Adverse Drug Reaction, Psychiatry, Psychotropic Drugs.

References